Banner

Archive for the ‘News’ Category

A New Device for Rapid Isolation by Size and Characterization of Rare Circulating Tumor Cells

Icon Written by ScreenCell on March 28, 2011 – 10:59 am

Abstract. Background: Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for all biological tests applying to the primary cells. Materials and Methods: The ScreenCell® devices are single-use and low-cost innovative devices that use a filter to isolate and sort tumor cells by size. Results: The […]



Melanoma Initiating Cells and Circulating Melanoma Cells: a Blurred Picture

Icon Written by ScreenCell on March 28, 2011 – 10:54 am

Whether a subset of tumorigenic cancer stem cells* exist in human melanomas remains a controversial issue though it is of critical importance in order since treatments which may eliminate the undifferentiated subset of cancer cells may cure patients (1,2). Therefore, it will be critical to identify cancer cells that have the tumorogenic potential in patients, […]



ScreenCell and the Caudius Regaud Cancer Institute start a new Partnership

Icon Written by ScreenCell on January 27, 2011 – 6:17 pm

ScreenCell and the Caudius Regaud Cancer Institute ( Toulouse , France ) are collaborating on the use of the ScreenCell technology for capturing and characterizing circulating tumor cells from patient blood samples. The partners will explore primarily the possibility of monitoring targeted therapy in patients with lung cancer. They expect their collaboration to contribute to […]



Personalized Medicine: Crizotinib, a New Targeted Therapy in Non–Small-Cell Lung Cancer

Icon Written by ScreenCell on November 11, 2010 – 4:44 pm

Personalized Medicine: Crizotinib, a New Targeted Therapy in Non–Small-Cell Lung Cancer. Anaplastic lymphoma kinase (ALK) is an orphan receptor tyrosine kinase first identified as part of the t(2;5) chromosomal translocation associated with most anaplastic large cell lymphomas (ALCL) and a subset of T-cell non-Hodgkins lymphomas. The deregulated expression of full length ALK and ALK fusions […]



Welcome to ScreenCell

Icon Written by ScreenCell on November 10, 2010 – 12:30 am

ScreenCell® Biomedical research solutions for non-invasive approach to: Drug Development Personalized Medicine Patient Monitoring in cancer Non-invasive prenatal diagnostics ScreenCell® is a non-invasive technology for isolation of Circulating Rare Cells (CRCs) from whole blood, and potentially any atypical cell in biological fluids. By providing an easy access to fixed or live Circulating Tumor Cells (CTCs) and Circulating […]

Tags: